Abstract:Background The presence of inducible myocardial ischaemia is used to select patients with stable coronary artery disease for revascularisation, based on observational data in patients with preserved left ventricular function. It is unclear if identification of a substrate for ischaemia is prognostic in patients with severe ischaemic left ventricular systolic dysfunction (LVSD). Purpose To determine if the extent of inducible ischaemia by stress perfusion CMR relates to clinical outcomes and/or the response to revascularisation in patients with ischaemic LVSD. Methods Patients enrolled in the REVIVED-BCIS2 randomised trial were eligible for inclusion if they had undergone stress perfusion CMR prior to randomisation (1). Visual assessment of myocardial perfusion and late gadolinium enhancement (LGE) was performed by an independent core laboratory, by consensus of two expert readers who were blinded to trial-group assignment and clinical or outcome data. For this analysis, segmental ischaemia was classified in a binary manner and the overall volume of ischaemia is expressed in relation to total LV mass, defined as [number of ischaemic segments]/16 * 100. The primary composite outcome was all-cause death or aborted sudden death. Secondary outcomes included left ventricular ejection fraction change at 6 and 12-months, cardiovascular death and sustained ventricular arrhythmias. Data are presented as median [IQR] or mean ± standard deviation. Results Of 700 participants enrolled, stress perfusion CMR was acquired in 200, 181 of whom had scans of sufficient quality for core laboratory analysis (91 randomised to percutaneous coronary intervention and 90 to optimal medical therapy; age 69±8 years, 86% male, 40% diabetic, baseline jeopardy score 10 [8-12]). On CMR, LVEF was 28±8%, scar burden was 18% [9-26] and ischaemic burden was 31% [13-56]. There was no association between ischaemic burden and the primary outcome (HR 1.0, p=0.997, CI 0.92-1.09) or any of the secondary outcomes (Figure 1). There was no relationship between ischaemia and randomised treatment group (Figure 2). Conclusion The REVIVED-BCIS2 trial incudes the largest cohort to date of stress perfusion CMR in severe LVSD, randomised to relief of ischaemia or medical therapy alone. In this study, ischaemic burden was not associated with clinical outcomes or the outcome following revascularisation.Figure 1 – HRs for 10% ischaemic burdenFigure 2 - KM plots for primary outcome

Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction

Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms

Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable …

Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?

Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary …

Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse …

[Myocardial viability: when and how to look for it, its prognostic impact and interaction with benefits of revascularization]

Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability

Early versus delayed revascularization in patients with ischemic cardiomyopathy and substantial viability: impact on outcome

Impact of Viable Myocardium Assessed by 99Tcm-Mibi SPECT and 18F-FDG PET Imaging on Clinical Outcome of Patients with Left Ventricular Aneurysm Underwent Revascularization

Mid-Term Results of Coronary Bypass Graft Surgery in Patients with Ischaemic Left Ventricular Systolic Dysfunction and No Detected Myocardial Viability

Off-pump Coronary Artery Bypass Surgery Outcomes in Patients with Ischaemic Left Ventricular Systolic Dysfunction with or Without Detected Viable Myocardium.

Long-term Survival of Patients with Viable and Nonviable Aneurysms Assessed by 99Mtc-Mibi SPECT and 18F-FDG PET: a Comparative Study of Medical and Surgical Treatment.

Effect of Coronary Revascularization on the Prognosis of Patients of Coronary Artery Disease Complicated with Heart Failure

Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How

Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study

The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy

Impact for Incomplete Correction of Myocardial Ischemia on Long-term Prognosis in Patients With Revascularization

The prognostic impact of inducible ischemia in severe ischaemic cardiomyopathy: a randomised comparison of medical therapy and revascularisation

Viable Myocardium Impact on Left Ventricular Function after Late Revascularization of Infarct-related Artery in Acute Myocardial Infarction

Effects Of Myocardial Viability And Left Ventricular Remodeling On Survival Of Patients With Heart Failure And Reduced Ejection Fraction After Coronary Artery Bypass Grafting